On December 12, 2025, members of the Canadian Cholangiocarcinoma Collaborative (C3) travelled to Houston, Texas and attended the Cholangiocarcinoma Foundation's (CCF) Houston Day Symposium to connect, learn, and bring back the latest advances in biliary tract cancer (BTC) research and care to our Canadian community. Houston is one of the world’s leading hubs for cholangiocarcinoma research, home to high-volume centres such as MD Anderson Cancer Center  and Houston Methodist C

I wanted to share a short summary of key themes and insights from the 2025 Canadian Cancer Research Conference (CCRC), held in Calgary earlier this month. While the event covered all cancer types, many sessions touched on topics that are especially relevant for those affected by cholangiocarcinoma and other rare or gastrointestinal cancers.   I attended alongside 3 C3 sponsored patients: Cynthia Mitchell, Corri Desaulniers, and Heba Affifi. L to R: Christine Lafontaine, Cynth